| Name | Title | Contact Details |
|---|
Perimeter Institute for Theoretical Physics is a basic research centre dedicated to exploring the world around us at its most fundamental level.
Beebe Medical Center, founded in 1916, is a not-for-profit community medical center governed by a volunteer Board of Trustees. Beebe has become the premier healthcare facility in Sussex County, serving a thriving beach and vacation resort area and a growing year-round population. Beebe provides comprehensive inpatient, outpatient, emergency, and home care in medical-surgical, obstetrics, pediatrics, oncology, and critical-care medicine. Outpatient services include an Outpatient Surgical Center, Diagnostic Imaging Centers, and Rehabilitation. Beebe Medical Center serves as a teaching facility for many regional allied health and professional education programs. Clinical practicums/experience are available in all continuums of care. Beebe Medical Center is fully accredited by the Joint Commission on Accreditation of Healthcare Organizations.
Meet Twiage: An award-winning mobile communication technology that enables hospitals and EMS to accelerate life-saving emergency care by reducing the need of radio and phone communication. Twiage offers Hospitals & Emergency Departments: - Real-time prehospital clinical data for Stroke, STEMI, Trauma, and Sepsis, as well as all other EMS transports - HIPAA-compliant Videos, Photos, and EKGs - Patient Pre-Registration - GPS-tagged ETA for every incoming ambulance, optimizing ED flow and triage - Two-way communication capabilities for intra-hospital care coordination and inter-facility transfers. Twiage offers EMS: - Faster handoffs and ED turnaround times - No more reliance on radios! - HIPAA-compliant video, photos, and data capture sent directly to entire hospital teams - Simple, evidence-driven algorithms that help improve quality handoffs - Ability to create custom algorithms to match your clinical protocols Awards: Pulse @ MassChallenge, Platinum Award, 2017 MATTER Chicago, Observation Unit Challenge - Winner, 2017 American Heart/Stroke Association, Health Tech Competition - People`s Choice Award, 2016 American Medical Association, Healthier Nation Challenge - 1st Place Winner, 2016 Aspen Institute, Spotlight Health Finalist, 2016 Cornell Venture Challenge - 2nd Place Winner, 2016 Cleveland Clinic, New Ventures Healthcare Challenge - Winner, 2015 Massachusetts Medical Society, Information Technology Award, 2014 mHealth, Rockstar of the Year for most meaningful mobile health technology, 2014
Healthcare Network Inc is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Discovery Laboratories, Inc. is a specialty biotechnology company focused on advancing a new standard in respiratory critical care. Discovery Labs` technology platform includes its novel proprietary KL4 surfactant, a synthetic, peptide-containing surfactant that is structurally similar to pulmonary surfactant, and its proprietary drug delivery technologies being developed to enable efficient delivery of aerosolized KL4 surfactant and other inhaled therapies. Discovery Labs` strategy is initially focused on neonatology and improving the management of respiratory distress syndrome (RDS) in premature infants. Discovery Labs believes that its RDS product portfolio has the potential to become the new standard of care for RDS and, over time, enable the treatment of a significantly greater number of premature infants who could benefit from surfactant therapy that are currently not being treated. In many pulmonary diseases, including RDS, acute lung injury (ALI), and other respiratory conditions, surfactant is either deficient or may fail to function properly. Our precision-engineered, peptide-containing KL4 surfactant has been designed to mimic the essential function of human pulmonary surfactant and may have the potential to address conditions such as these. We are developing our proprietary delivery technologies to one day enable efficient, targeted upper-respiratory or alveolar delivery of our KL4 surfactant in aerosolized form to allow for a gentler, less invasive delivery approach. These same delivery systems may also potentially be used to deliver a variety of additional aerosolized medicines safely and in a simplified way compared with the current standard of care.